Tran-Scell Biologics Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.42 Cr
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.55 Cr
- Revenue Growth -36.79%
- Profit Growth -17.51%
- Ebitda -82.80%
- Net Worth -12.26%
- Total Assets -9.74%
About Tran-Scell Biologics
Tran-Scell Biologics Private Limited (TBPL) is Amalgamated company established on 07 Dec 2009 with its office registered at Hyderabad, Telangana, India and has been running since 15 Year, 5 Months with a paid up capital of 2.42 Cr. According to MCA records, 4 Directors are linked to this company as of 16 Jan 2025.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100TG2009PTC066172
- Company No.
066172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
Tran-Scell Biologics Private Limited
Explore comprehensive data for Tran-Scell Biologics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Tran-Scell Biologics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhadra Dravida  | Managing Director | 07-Dec-2009 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uday Chatterjee | Director | 11-May-2020 | Current |
| Vinayender Tulla | Director | 05-Oct-2015 | Current |
Asif Hasan  | Additional Director | 25-Jul-2024 | Current |
Financial Performance of Tran-Scell Biologics.
Tran-Scell Biologics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.79% decrease. The company also saw a substantial fall in profitability, with a 17.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tran-Scell Biologics?
In 2023, Tran-Scell Biologics had a promoter holding of 62.39% and a public holding of 37.61%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Venkateshwara Multiplexes Private LimitedVinayender Tulla is a mutual person
Canter Technologies Private LimitedVinayender Tulla is a mutual person
Quantiphi Analytics Solutions Private LimitedAsif Hasan is a mutual person
- Transcell Biosciences Private Limited
Subhadra Dravida and Uday Chatterjee are mutual person
Gostops Hospitality Private LimitedUday Chatterjee is a mutual person
Transtox Bioapplications Private LimitedSubhadra Dravida is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.55 Cr
Charges Breakdown by Lending Institutions
- Andhra Pradesh State Financial Corporation : 1.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2010 | Andhra Pradesh State Financial Corporation | ₹1.55 Cr | Satisfied |
How Many Employees Work at Tran-Scell Biologics?
Unlock and access historical data on people associated with Tran-Scell Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tran-Scell Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tran-Scell Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Tran-Scell Biologics
Recent activity within the organization
- Director Appointment
Asif Wahidul Hasan was appointed as a Additional Director was appointed as a Additional Director on 25 Jul 2024 & has been associated with this company since 9 months 29 days .
- Annual General Meeting
Tran-Scell Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Tran-Scell Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Uday Chatterjee was appointed as a Director was appointed as a Director on 11 May 2020 & has been associated with this company since 5 years 12 days .
- Charges
A charge registered on 21 May 2010 via Charge ID 10226533 with Andhra Pradesh State Financial Corporation was fully satisfied on 28 Aug 2019.
- Director Appointment
Vinayender Tulla was appointed as a Director was appointed as a Director on 05 Oct 2015 & has been associated with this company since 9 years 7 months .
Recent News, Updates & Announcement
- Entertainment app Roast gets funding from Indian Angel Network.
Delhi-based Roast Media Pvt. Ltd, which operates mobile entertainment app Roast, has raised an undisclosed amount in funding from Indian Angel Network (IAN). The funding was led by Sanjay Mehta who will also join the company’s board..
- Transcell Biologics raises funds from Indian Angel Network | Mint.
The company plans to use the investment to develop products out of stem cell based platforms in both the therapeutic and non-therapeutic areas.
- "Girls Dominate Startup Funding: 9 Badass Women-Led Startups Making Waves in 2016".
"Girls are killing it in the startup game! In 2016, 17 startups with female co-founders got funding, a 183% increase from last year. But let's be real, guys still dominate. But hey, progress is progress! Check out these 9 badass women-led startups that got funding recently. #GirlPower #StartupGoals".
Frequently asked questions
What is the Incorporation or founding date of Tran-Scell Biologics Private Limited?
Tran-Scell Biologics Private Limited was incorporated on 07 Dec 2009.
What is authorized share capital and paid-up capital of Tran-Scell Biologics Private Limited?
The authorized share capital of Tran-Scell Biologics Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 2.42 Cr.
Who are the current board members & directors of Tran-Scell Biologics Private Limited?
Currently 4 directors are associated with Tran-Scell Biologics Private Limited.
- Asif Wahidul Hasan
- Subhadra Dravida
- Vinayender Tulla
- Uday Chatterjee
What is the registered address of Tran-Scell Biologics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Tran-Scell Biologics Private Limited is 8Th Floor Western Pearl, Kondapur India, Hyderabad, Telangana, 500084.
What is the corporate identification number (CIN) and company number of Tran-Scell Biologics Private Limited?
The corporate identification number (CIN) of Tran-Scell Biologics Private Limited is U85100TG2009PTC066172 and the company number is 066172 as per Ministry of Corporate Affairs (MCA).
What is the official website of Tran-Scell Biologics Private Limited?
The Official website of Tran-Scell Biologics Private Limited is https://www.transcell.in
What has been the recent revenue trend for Tran-Scell Biologics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Tran-Scell Biologics Private Limited has fallen by -36.79%.
What change has been observed in the net worth of Tran-Scell Biologics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Tran-Scell Biologics Private Limited has experienced an downturn of -12.26%.
When was the last Balance Sheet of Tran-Scell Biologics Private Limited filed with the ROC?
The most recent Balance Sheet for Tran-Scell Biologics Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Yeduguri ReddyAdditional Director
Sundari PisupatiDirector
Raviprasad PisupatiDirectorBB
Bhim BajajDirectorKR
Krishna ReddyDirectorSJ
Sanjay JesraniDirector and DirectorDM
Dkrishna MohanDirectorSJ
Sanjay JesraniDirector and Director
Similar Companies Based on Diabetes Care & Endocrinology Clinics
Sunils Diabetes Care N Research Centre Private Limited Nagpur, Maharashtra, India
Herbocare Hospital Private Limited Erode, Tamil Nadu, India
Oivi Tech Private Limited Bangaluru, Karnataka, India
Dr.Mohan's Diabetes Specialities Centre Private Limited Chennai, Tamil Nadu, India
Dr.Ramachandran S Diabetes Care Private Limited Chennai, Tamil Nadu, India
Kanungo Institute Of Diabetes Specialities Private Limited Khorda, Odisha, India
M V Hospital For Diabetes Private Limited Chennai, Tamil Nadu, India
Apollo Sugar Clinics Limited Hyderabad, Telangana, India